Moleculin Biotech, INC. (MBRX) — S-1/A Filings
All S-1/A filings from Moleculin Biotech, INC.. Browse 3 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (3)
-
Moleculin Biotech Files S-1/A for Continuous Offering
— Jun 16, 2025 Risk: high
Moleculin Biotech, Inc. (MBRX) filed an S-1/A on June 16, 2025, for a delayed or continuous offering of securities under Rule 415, indicating a strategic move t -
Moleculin Biotech Files S-1/A for Continuous Offering
— Jun 11, 2025 Risk: high
Moleculin Biotech, Inc. (MBRX) filed an S-1/A on June 11, 2025, for a delayed or continuous offering of securities under Rule 415, indicating a potential capita -
Moleculin Biotech Amends S-1, Signals Future Capital Raise
— Jun 6, 2025 Risk: high
Moleculin Biotech, Inc. (MBRX) filed an S-1/A on June 6, 2025, for a delayed or continuous offering of securities under Rule 415, indicating a strategic move to
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX